Subtitle
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
Subtitle
Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer.
Proto therapy Time
February 2023
Executive summary
Published in JAMA, this study reported the prevalence and clinical characteristics of ORN in patients with oral and oropharyngeal cancer (OOPC) treated with PRT. Of the 122 patients included in this study, 13 (10.6%) developed ORN following PRT during a median (range) follow-up time of 40.6 months. The posterior ipsilateral mandible within the radiation field that received the full planned PRT dose was the most involved ORN site. The authors concluded that ORN remains a clinical challenge even in the era of highly conformal PRT.
Top cancer treatments
Related contents
Proton Therapy Publication
September 2024
The Potential and Challenges of Proton FLASH in Head and Neck Cancer Reirradiation.
Proton Therapy Publication
May 2024
Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic Carcinoma.
Proton Therapy Publication
June 2024
Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.
Proton Therapy Publication
May 2024
Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.
Proton Therapy Publication
August 2024
Proton Therapy in The Treatment of Head And Neck Cancers- Review.
Webinar
Phase III randomized trial of IMPT versus IMRT for the treatment of head and neck oropharyngeal carcinoma (OPC)
An Interview with Dr. Steven Frank
Steven
Frank
Proton Therapy Publication
June 2024
Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT)
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.